Leukemoid reaction is a benign, reactive process with elevated LAP & no Philadelphia chromosome, unlike malignant CML.
Causes of Atypical Lymphocytes (Reactive Lymphocytes)
Atypical lymphocytes are activated immune cells, often seen in infections. Their unique look aids diagnosis, but distinguishing it from cancer is important.
Hypersensitivity Reactions: Causes and Mechanisms
Hypersensitivity is an exaggerated, undesirable immune response to an antigen, causing tissue damage. It encompasses four types: IgE-mediated (allergies), cytotoxic, immune complex, and delayed cell-mediated reactions.

Eosinophilic Asthma
Eosinophilic asthma is a severe subtype of asthma, driven by high eosinophil levels. It often resists standard treatments and may not be allergy-related.

Hypereosinophilic Syndrome (HES)
Hypereosinophilic Syndrome (HES) is a rare disorder causing persistently high eosinophil levels, leading to organ damage and inflammation.

Leukemoid Reaction
Leukemoid reaction is a benign, reactive process with elevated LAP & no Philadelphia chromosome, unlike malignant CML.
Classic Hodgkin Lymphoma Treatment Strategies
Hodgkin lymphoma explained: treatment, stages, and what to expect. Your guide based on the latest NCCN recommendations.
Causes of Polycythemia
Polycythemia has high red blood cell count. Learn causes, symptoms (headache, fatigue), diagnosis (CBC, EPO), and treatment options.
Neutropenia
Neutropenia is a condition with a low count of neutrophils, key infection-fighting white blood cells. This increases susceptibility to various infections.
Infectious Mononucleosis (Mono)
Infectious mononucleosis (Mono), the “kissing disease,” is a common viral illness (EBV). Symptoms include sore throat, fever, fatigue, and swollen glands. Usually resolves on its own.
Causes of Eosinophilia (High Eosinophils)
High eosinophil count in blood. May indicate allergies, infections, or other conditions. Symptoms vary. Diagnosis via blood test.
Chronic Myeloid Leukemia Treatment Strategies
Chronic Myeloid Leukemia Treatment: TKIs are the main therapy, targeting the BCR::ABL1 gene. Chemotherapy & stem cell transplant are also used.